Dermata Therapeutics, Inc. (DRMA)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Sep 04, 16:00
1.24
+0.03
(+2.48%)
After-Hours: 20:00
Dermata Therapeutics Total Assets (Quarterly) : 5.321M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.321M |
| March 31, 2026 | 7.466M |
| December 31, 2025 | 7.864M |
| September 30, 2025 | 5.071M |
| June 30, 2025 | 6.640M |
| March 31, 2025 | 10.00M |
| December 31, 2024 | 3.534M |
| September 30, 2024 | 6.687M |
| June 30, 2024 | 5.237M |
| March 31, 2024 | 5.180M |
| December 31, 2023 | 7.979M |
| Date | Value |
|---|---|
| September 30, 2023 | 7.323M |
| June 30, 2023 | 8.713M |
| March 31, 2023 | 9.295M |
| December 31, 2022 | 6.944M |
| September 30, 2022 | 8.975M |
| June 30, 2022 | 11.03M |
| March 31, 2022 | 9.044M |
| December 31, 2021 | 11.62M |
| September 30, 2021 | 13.69M |
| June 30, 2021 | 1.137M |
| March 31, 2021 | 1.651M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 183.47M |
| Perspective Therapeutics, Inc. | 392.02M |
| MiMedx Group, Inc. | 281.00M |
| ABVC BioPharma, Inc. | 19.40M |
| Endonovo Therapeutics, Inc. | 0.0448M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.833M |
| Shareholders Equity (Quarterly) | 3.488M |
| Current Ratio | 2.803 |